A HANDS-ON MANUAL FOR IDENTIFYING AND TREATING HEART FAILURE IN CHILDREN
DOI:
https://doi.org/10.53555/nnmhs.v9i7.1747Keywords:
Myocarditis, Congenital heart abnormalities, Pediatric heart transplantation, Pediatric heart failureAbstract
The incidence of heart failure among children constitutes a major cause of sickness and mortality during their initial years of existence. Whereas well-established guidelines are present for managing heart failure in adults, a corresponding consensus for the pediatric group is lacking. Within a healthcare setting, it's of paramount importance to establish a correct diagnosis and identify the root cause for the most effective intervention. Primary interventions include diuretics and angiotensin-converting enzyme inhibitors, however, the utilization of beta-blockers and cardiac therapy devices is less common in pediatric cases as compared to adults. For severe conditions, heart transplant remains the goto therapeutic choice. Additionally, left ventricular assist devices can be employed as a temporary solution awaiting transplantation (due to scarcity of organ donors), recovery (in instances of myocarditis), or a definitive solution (for patients with systemic disease).
References
Rossano JW, Shaddy RE. Heart failure in children: etiology and treatment. J Pediatr. 2014;165:228-33.
Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic
heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2016;18:891-975.
Kaski JP, Limongelli G. Cardiomyopathy in children: importance of aetiology in prognosis. Lancet. 2014;383:7812.
Johnson FL. Pathophysiology and etiology of heart failure. Cardiol Clin. 2014;32:9-19.
Kantor PF, Lougheed J, Dancea A, McGillion M, Barbosa N, Chan C, et al. Presentation, diagnosis, and medical management of heart failure in children: Canadian Cardiovascular Society guidelines. Can J Cardiol. 2013;29:153552.
Mitchell FM, Prasad SK, Greil GF, Drivas P, Vassiliou VS, Raphael CE. Cardiovascular magnetic resonance: diagnostic utility and specific considerations in the pediatric population. World J Clin Pediatr. 2016;5:1-15.
Stout KK, Broberg CS, Book WM, Cecchin F, Chen JM, Dimopoulos K, et al. Chronic Heart failure in congenital heart disease: a scientific statement from the American Heart Association. Circulation. 2016;133:770-801.
Kirk R, Dipchand AI, Rosenthal DN, Addonizio L, Burch M, Chrisant M, et al. The International Society for Heart and Lung Transplantation Guidelines for the management of pediatric heart failure: executive summary. J Heart Lung Transplant. 2014;33:888-909.
Hussey AD, Weintraub RG. Drug treatment of heart failure in children: focus on recent recommendations from the ISHLT Guidelines for the Management of Pediatric Heart Failure. Paediatr Drugs. 2016;18:89-99.
Alabed S, Sabouni A, Al Dakhoul S, Bdaiwi Y, Frobel-Mercier AK. Beta-blockers for congestive heart failure in children. Cochrane Database Syst Rev. 2016;(1):CD007037.
Angadi U, Westrope C, Chowdhry MF. Is levosimendan effective in paediatric heart failure and post-cardiac surgeries? Interact Cardiovasc Thorac Surg. 2013;17:710-4.
Motonaga KS, Dubin AM. Cardiac resynchronization therapy for pediatric patients with heart failure and congenital heart disease a reappraisal of results. Circulation. 2014;129:1879-91.
Kirk JA, Kass DA. Electromechanical dyssynchrony and resynchronization of the failing heart. Circ Res. 2013;113:765-6.
Masarone D, Limongelli G, Ammendola E, Del Giorno G, Colimodio F, D’Andrea A, et al. Cardiac resynchronization therapy in cardiomyopathies. J Cardiovasc Med (Hagerstown). 2014;15:92-9.
Lorts A, Zafar F, Adachi I, Morales DL. Mechanical assist devices in neonates and infants. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu. 2014;7:91-5.
Dipchand AI, Kirk R, Edwards LB, Kucheryavaya AY, Benden C, Christie JD, et al. The Registry of the International Society for Heart and Lung Transplantation: Sixteenth Official Pediatric Heart Transplantation Report-2013; focus theme: age. J Heart Lung Transplant. 2013;32:979-88.
Kobayashi D, Du W, L’ecuyer TJ. Predictors of cardiac allograft vasculopathy in pediatric heart transplant recipients. Pediatr Transplant. 2013;17:436-40.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Licensing
Ninety Nine Publication publishes articles under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This licensing allows for any use of the work, provided the original author(s) and source are credited, thereby facilitating the free exchange and use of research for the advancement of knowledge.
Detailed Licensing Terms
Attribution (BY): Users must give appropriate credit, provide a link to the license, and indicate if changes were made. Users may do so in any reasonable manner, but not in any way that suggests the licensor endorses them or their use.
No Additional Restrictions: Users may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
